Our results confirm SSO mediated pseudoexon skipping as a potential therapeutic approach for PTPS deficiency and point to the identification of high risk sites for the activation of Alu-derived pseudoexons. Here, PTS is linked to hyperinsulinemic hypoglycemia, familial, 4.